Treace Medical Concepts, Inc.
TMCI
$6.72
$0.060.90%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.55% | -29.09% | -50.66% | -15.91% | -15.68% |
| Total Depreciation and Amortization | 52.91% | 65.58% | 102.00% | 114.36% | 127.47% |
| Total Amortization of Deferred Charges | 62.86% | 167.45% | 168.69% | 192.31% | 226.64% |
| Total Other Non-Cash Items | 85.30% | 87.51% | 108.26% | 41.14% | 22.10% |
| Change in Net Operating Assets | -161.04% | 29.13% | 77.17% | 97.41% | -67.72% |
| Cash from Operations | -7.50% | 19.86% | 21.69% | 39.66% | -12.81% |
| Capital Expenditure | -1.18% | 6.71% | 17.94% | 6.26% | 22.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 194.24% | 140.18% | 137.20% | 126.19% | 19.19% |
| Cash from Investing | 143.51% | 124.59% | 122.26% | 101.89% | -6.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.65% | -99.55% | -92.93% | -93.21% | 5,534.02% |
| Repurchase of Common Stock | 95.77% | 96.04% | 96.04% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | 100.00% | -658.34% |
| Cash from Financing | -99.85% | -99.73% | -99.59% | -98.96% | 425.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.86% | 105.95% | 106.87% | 70.55% | 92.48% |